Document Detail


Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma.
MedLine Citation:
PMID:  19156409     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To evaluate the diagnostic accuracy of contrast-enhanced FDG-PET/CT (ce-PET/CT), PET-only, and CT-only in patients with newly diagnosed and resected cutaneous malignant melanoma. METHODS: A final group of 56 patients (mean age 62 years, range 23-86 years; 29 women, 27 men) were staged with ce-PET/CT after resection of the primary tumour. Histopathology as well as clinical follow-up (mean 780 days, range 102-1,390 days) served as the standards of reference. Differences between the staging modalities were tested for statistical significance with McNemar's test. RESULTS: All imaging procedures provided low sensitivities in the detection of lymph nodes (sensitivity N-stage: PET/CT and PET-only 38.5%; CT-only 23.1%) and distant metastases (sensitivity M-stage: PET/CT 41.7%, PET-only 33.3%, CT-only 25.0%) in initial staging after resection of the primary tumour. No statistically significant differences were detected between the imaging procedures (p > 0.05). PET/CT resulted in an alteration in further treatment in two patients compared to PET-only and in four patients compared to CT-only. CONCLUSION: All imaging modalities had a low sensitivity on initial staging of patients with malignant melanoma. Thus, close patient follow-up must be considered mandatory.
Authors:
Patrick Veit-Haibach; Florian M Vogt; Robert Jablonka; Hilmar Kuehl; Andreas Bockisch; Thomas Beyer; Gerlinde Dahmen; Sandra Rosenbaum; Gerald Antoch
Related Documents :
17541519 - Postmortem computed tomography and magnetic resonance imaging in a case of terminal-sta...
17631559 - 68ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: compari...
17180659 - Integrated pet/ct as a first-line re-staging modality in patients with suspected recurr...
17312829 - Fdg-pet scanning in the management of cancer of the oesophagus and oesophagogastric jun...
18539889 - Non-small cell lung cancer: whole-body mr examination for m-stage assessment--utility f...
17198889 - Integrated ct-pet imaging of esophageal cancer: unexpected and unusual distribution of ...
15607859 - Magnetic resonance imaging of trabecular and cortical bone in mice: comparison of high ...
6272419 - Current status of radionuclide scrotal imaging.
14676719 - Imaging features of brain tuberculoma in tanzania: case report and literature review.
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2009-01-21
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  36     ISSN:  1619-7089     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-11     Completed Date:  2009-07-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  910-8     Citation Subset:  IM    
Affiliation:
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany. patrick.veit-haibach@usz.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Contrast Media / diagnostic use*
Female
Fluorodeoxyglucose F18 / diagnostic use*
Follow-Up Studies
Humans
Male
Melanoma / diagnosis*,  pathology*,  radiography,  radionuclide imaging
Middle Aged
Neoplasm Metastasis / radiography,  radionuclide imaging
Neoplasm Staging
Positron-Emission Tomography
Sensitivity and Specificity
Skin Neoplasms / diagnosis*,  pathology*,  radiography,  radionuclide imaging
Time Factors
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
0/Contrast Media; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Discovery of a pimaricin analog JBIR-13, from Streptomyces bicolor NBRC 12746 as predicted by sequen...
Next Document:  Chronic thyroiditis in patients with advanced breast carcinoma: metabolic and morphologic changes on...